Table 3 Unobserved induction outcomes
From: Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
Induction outcome | n (%) |
|---|---|
Unobserved induction cases | 305 (100) |
Lost to follow-up at week 1 | 52 (17) |
≥1 induction-related adverse event (AE) | 38 (13) |
Precipitated withdrawal | 10 (3) |
Prolonged withdrawal | 13 (4) |
Serious adverse event (SAE) | 0 (0) |
Other induction-related AEa | 15 (5) |